Most Recent
Ex-Linchpin director loses appeal of $150,000 penalty
The director of collapsed investment firm Linchpin Capital has lost his challenge to a $150,000 penalty, with an appeals court dismissing his arguments as “carping criticism”.
Suit alleges barrister used $1.3M of his company’s funds for chambers fees
Shareholders in lending platform Marketlend can bring a derivative suit against its directors for allegedly misusing company funds, including spending $1.3 million on barrister chambers fees. 
‘Horse has bolted’: Judge declasses COVID-19 insurance class actions
Four proceedings over COVID-19 business interruption losses will be stripped of class action status, with a judge saying most of the common issues were already determined in test cases.
CBA class actions win halt to costs battle pending appeal
Applicants in two dismissed class actions against the Commonwealth Bank have secured an order staying an assessment of costs in the failed cases until the outcome of an appeal.
Advanta Seeds can’t force licensee Nuseed to fix seed labels
The developer of a Canola seed hybrid tolerant to herbicide has lost a bid for seed grower Nuseed to relabel its products, which are already stocked in 361 retail locations.
Insurers on hook for Opal Tower class action costs after failed appeal
Two insurers have come up short in their appeal of a ruling that put them on the hook for the costs of Opal Tower consultant engineer WSP in a class action by residents.
No ‘bottomless pit’: Class action administrator put on notice about costs
An administrator has won $1 million more in costs for distributing a class action settlement, but a judge warned any ‘overshoot’ might not be borne by group members.
CIMIC loses appeal against insurers over coverage for Iraq bribery cases
Insurers have won a challenge to a declaration that engineering firm CIMIC could make claims under policies for costs arising from corruption cases, including a $32 million class action settlement.
Self Care wins IP action over FreezeFrame knockoffs
Cosmetics maker Self Care has won its case against companies with ties to China that were found to have sold counterfeit versions of its popular Freezeframe anti-ageing creams. 
Alceon hit with $3M in damages for ‘misleading’ sale of Qld shopping centre
Private equity firm Alceon and a vendor have been hit with $3 million damages over the misleading sale of a Queensland shopping centre for $55 million.